Bank of Montreal’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-97,903
Closed -$1.02M 3554
2021
Q3
$1.02M Sell
97,903
-5,031
-5% -$51.2K ﹤0.01% 2483
2021
Q2
$1.09M Buy
102,934
+28,922
+39% +$293K ﹤0.01% 2435
2021
Q1
$842K Sell
74,012
-21,824
-23% -$253K ﹤0.01% 2319
2020
Q4
$1.02M Sell
95,836
-45
-0% -$464 ﹤0.01% 2233
2020
Q3
$893K Sell
95,881
-7,682
-7% -$68.4K ﹤0.01% 2034
2020
Q2
$971K Buy
103,563
+4,870
+5% +$41.5K ﹤0.01% 1939
2020
Q1
$667K Buy
98,693
+6,718
+7% +$47K ﹤0.01% 1858
2019
Q4
$766K Buy
+91,975
New +$568K ﹤0.01% 2431
2019
Q2
Sell
-14,288
Closed -$140K 4884
2019
Q1
$140K Hold
14,288
﹤0.01% 2906
2018
Q4
$112K Hold
14,288
﹤0.01% 2894
2018
Q3
$250K Buy
+14,288
New +$127K ﹤0.01% 2632

Other funds holding CSBR

Bank of Montreal's CSBR Position: Q4 2021 in Review

Bank of Montreal sold out of Champions Oncology (CSBR) in Q4 2021, closing a stake of 97,903 shares — an estimated $1.02M sold.

Bank of Montreal first reported a position in CSBR in Q3 2018 and held it in 11 quarters. The position peaked at $1.09M in Q2 2021. 31 funds tracked by Wall St. Rank hold CSBR as of Q4 2021.

  • Bank of Montreal reported no remaining Champions Oncology position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 97,903 Champions Oncology shares in Q4 2021, an estimated $1.02M.
  • Bank of Montreal first reported a position in Champions Oncology in Q3 2018 and held it in 11 quarters.
  • Bank of Montreal's Champions Oncology position peaked at $1.09M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.